PROTOSCRIPT Trademark

Trademark Overview

On Wednesday, July 15, 2009, a trademark application was filed for PROTOSCRIPT with the United States Patent and Trademark Office. The USPTO has given the PROTOSCRIPT trademark a serial number of 77781426. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, October 15, 2019. This trademark is owned by New England Biolabs, Inc.. The PROTOSCRIPT trademark is filed in the Chemical Products category with the following description:

Reagents for research use [; diagnostic reagents for clinical or medical laboratory use]
protoscript

General Information

Serial Number77781426
Word MarkPROTOSCRIPT
Filing DateWednesday, July 15, 2009
Status800 - REGISTERED AND RENEWED
Status DateTuesday, October 15, 2019
Registration Number3836779
Registration DateTuesday, August 24, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2010

Trademark Statements

Pseudo MarkPROTO SCRIPT
Goods and ServicesReagents for research use [; diagnostic reagents for clinical or medical laboratory use]

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, July 20, 2009
Primary Code001
First Use Anywhere DateFriday, June 5, 2009
First Use In Commerce DateFriday, June 5, 2009

Trademark Owner History

Party NameNew England Biolabs, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIpswich, MA 01938
Party NameNew England Biolabs, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIpswich, MA 01938
Party NameNew England Biolabs, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIpswich, MA 01938

Trademark Events

Event DateEvent Description
Wednesday, October 4, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 15, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, October 15, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, October 15, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, October 15, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 9, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 9, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, August 24, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 6, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, November 6, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 6, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 17, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 24, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, June 8, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2010PUBLISHED FOR OPPOSITION
Monday, May 3, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 3, 2010ASSIGNED TO LIE
Wednesday, April 21, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 14, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 14, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 14, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 15, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 15, 2009NON-FINAL ACTION E-MAILED
Thursday, October 15, 2009NON-FINAL ACTION WRITTEN
Thursday, October 15, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 15, 2009NON-FINAL ACTION E-MAILED
Thursday, October 15, 2009NON-FINAL ACTION WRITTEN
Wednesday, October 14, 2009ASSIGNED TO EXAMINER
Tuesday, July 21, 2009NOTICE OF PSEUDO MARK MAILED
Monday, July 20, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 18, 2009NEW APPLICATION ENTERED

Related Keywords

protoscript reagents laboratory medical diagnostic research clinical